**To**
## **Trustees' Annual Report for the period**
Period start date 01 January 2020
Period end date 31 December 2020
**From**
## Section A Reference and administration details
**Charity name** Cancer Care Hospital & Research Charitable Trust
**Other names charity is known by Registered charity number (if any)** 1157272
**Charity's principal address** 45 Ellesmere Road
Greenford **Postcode** UB6 9ET
## **Names of the charity trustees who manage the charity**
|1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole year**|**Name of person (or body)**
**entitled to appoint trustee**
**(ifany)**|
|---|---|---|---|---|
||MR Mazhar Jamil Ansari|Chairman|Appointed on 17 June, 2018||
||DR Hammad Raza Sheikh|Trustee|Appointed on 17 June, 2018||
||MRS Sadia Riaz|Trustee|Appointed on 17 June, 2018||
||Prof Dr Nabeela Shami|Trustee|Appointed on 17 June, 2018||
||MRS Ghazala Tariq|Trustee|Appointed on 17 June, 2018||
||Prof Dr Shaharyar|Trustee|Appointed on 17 June, 2018||
||Dr Ehsan Ur-Rahman|Trustee|Appointed on 01 June, 2014||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
## **Names of the trustees for the charity, if any, (for example, any custodian trustees)**
**Name Dates acted if not for whole year**
**TAR**
December 2020
1
## **Names and addresses of advisers (Optional information)**
|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|
|---|---|---|
|**Type of adviser**
**Name**
**Address**|||
||||
||||
||||
||||
|**Name of chief executive or names of senior staff members (Optional information)**|||
||||
## **Section B Structure, governance and management**
## **Description of the charity’s trusts**
Type of governing document Constitution (eg. trust deed, constitution)
How the charity is constituted Association (eg. trust, association, company)
Trustee selection methods Elected (eg. appointed by, elected by)
## **Additional governance issues (Optional information)**
You **may choose** to include additional information, where relevant, about:
- policies and procedures adopted for the induction and training of trustees;
- the charity’s organisational structure and any wider network with which the charity works;
- relationship with any related parties;
- trustees’ consideration of major risks and the system and procedures to manage them.
## **Section C Objectives and activities**
**Summary of the objects of the charity set out in its governing document**
To promote health facilities related to cancer, cancer treatment, prevention, early detection, palliative care, terminal care, hospice care, cancer research, general medical care and medical science in general and medical science in relation to Cancer, medical education in general and education in field of Cancer and fields related to Cancer, in all respects up to best possible available facilities.
**TAR**
December 2020
2
The charity continued its fundraising activities with the help of its benefactors however its outreach has been limited due to COVID-19 related constraints.
**Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)**
## **Additional details of objectives and activities (Optional information)**
You **may choose** to include further statements, where relevant, about:
- policy on grantmaking;
- policy programme related investment;
- contribution made by volunteers.
## Section D Achievements and performance
**TAR**
December 2020
3
Section D Achievements and erformance p The charity continued its support to help the hospital in buying medical **Summary of the main** equipment for diagnosis and treatment of Cancer patients. The hospital **achievements of the charity** has already started seeing patients at the time this report is signed. **during the year** The hospital started its state of the art radio therapy centre during the year and thousands of procedures were undertaken during the year.
## **Section E Financial review**
Thanks to the contributions from its benefactors, The charity has a **Brief statement of the** minimum fixed operating cost. The charity intends to maintain a reserve **charity’s policy on reserves** of £3000 in its liquid funds. The charity maintained this reserve throughout the year and maintains a strong position to continue its operations. **Details of any funds materially in deficit**
**Further financial review details (Optional information)**
**TAR**
December 2020
4
You **may choose** to include additional information, where relevant about:
- the charity’s principal sources of funds (including any fundraising);
- how expenditure has supported the key objectives of the charity;
- investment policy and objectives including any ethical investment policy adopted.
## **Section F Other optional information**
## **Section G Declaration**
**The trustees declare that they have approved the trustees’ report above.**
## **Signed on behalf of the charity’s trustees**
**Signature(s) Full name(s)** Mazhar Jamil Ansari **Position (eg Secretary, Chair,** Chairman **etc) Date** 15/09/2021
**TAR**
December 2020
5
|**Cancer Care Hospital & Research Charitable Trust**|**Cancer Care Hospital & Research Charitable Trust**|**Cancer Care Hospital & Research Charitable Trust**|**1157272**|
|---|---|---|---|
|||||
|**Receipts andpayments accounts**||||
|**For the period**
**from**|01/01/2020|**To**|31/12/2020|
## **CC16a**
|**Section A Receipts and payments**|**Section A Receipts and payments**||||||
|---|---|---|---|---|---|---|
|**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**13,111**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**13,111**
**-**
**-**
**-**
**13,111**
**768**
**-**
**-**
**20,447**
**48**
**-**
**-**
**-**
**21,263**
**-**
**-**
**-**
**21,263**
**- 8,152**
**-**
**11,566**
**3,414**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Total funds**
**to the nearest £**
**13,111**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**13,111**
**-**
**-**
**-**
**13,111**
**-**
**768**
**-**
**-**
**20,447**
**48**
**-**
**-**
**-**
**21,263**
**-**
**-**
**-**
**21,263**
**- 8,152**||**Last year**
**to the nearest £**|
|Donations|**13,111**|||||**12,960**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**_(Gross income for_
_AR)_|**13,111**|||||**12,960**|
||||||||
|**A2 Asset and investment sales,**
**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
|**_Total receipts_**
**A3 Payments**|||||||
|||||||**12,960**|
||||||||
|Promotional activities||||||**460**|
|Accountancyfee|**768**|||||**712**|
|Support activities|**-**|||||**-**|
|Equipment|**-**|||||**32,661**|
|Legal andprofessional charges|**20,447**|||||**2,408**|
|Bank Charges|**48**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_ **|**21,263**|||||**36,241**|
||||||||
|**A4 Asset and investment**
**purchases, (see table)**|||||||
||**-**||||||
||**-**||||||
|**_Sub total_ **|**-**|||||**-**|
|**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||
|||||||**36,241**|
||||||||
||**- 8,152**|**-**|**-**|**- 8,152**||**- 23,281**|
||**-**|**-**|**-**|**-**||**-**|
||**11,566**|**-**|**-**|**11,566**||**34,847**|
||**3,414**|**-**|**-**|**3,414**||**11,566**|
CCXX R1 accounts (SS)
11/09/2021
1
## **Section B Statement of assets and liabilities at the end of the period**
|**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|Signature
**Details**
**Details**
Cash
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**3,414**
**-**
**-**
**-**
**-**
**-**
**3,414**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Mazhar Jamil Ansari|**Endowment**
**funds**
**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**
**funds**
**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**
**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**
**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**
**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of
approval|
|||Mazhar Jamil Ansari|15/09/2021|
|||||
CCXX R2 accounts (SS)
11/09/2021
2